filmov
tv
CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD
Показать описание
Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD. This webcast was designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases, with a focus on information shared among clinicians and researchers. Participants will gain insight from expert faculty on breakthroughs in cutting-edge research and in advancements in IBD patient care.
In this video, Dr. Asher A. Kornbluth presents: "CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD."
Earn accreditation for this activity at the following location:
© 2015 Imedex, LLC.
In this video, Dr. Asher A. Kornbluth presents: "CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD."
Earn accreditation for this activity at the following location:
© 2015 Imedex, LLC.
0:10:25
CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD
0:12:04
PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD
0:11:29
All You Need to Know about Biologics - How They Work, When to Use Them and The Common Side Effects
0:07:36
Debate: Is Combination therapy necessary if you use anti-TNF? - No, monotherapy will suffice
0:18:01
Key Insights: Reaching Beyond Anti-TNFs in Moderate to Severe Ulcerative Colitis
0:20:54
Selection and use of the non-anti-TNF biological therapies? Who? When? How?
0:15:27
Loss of Response to Anti-TNFs – What Should I Do Next?
0:19:10
Debate: Combination or monotherapy with anti-TNF? - Monotherapy
0:19:02
Use of Anti-TNF Antibodies, Drug Levels, and Other Serological Markers in IBD
0:18:38
Positioning anti-IL-12 and anti-IL-23 inhibitors
0:12:35
Best of the Day: ACG2016 - Anti-TNF Therapy
0:11:50
CON: Medications Should Never be Stopped for Crohn’s Disease Patients in Remission
0:18:01
Debate: Combination or monotherapy with anti-TNF? - Combination
0:13:30
Expert Perspectives on Anti-TNF Therapy in the Perioperative Period
0:04:30
Anti-TNF Therapy and Remission Rates in Pediatric Crohn's Disease - IBD in the News
0:13:24
PRO: Monotherapy Using 6-MP or Azathioprine for IBD is Dead
0:11:07
Humira /adalimumab for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis
0:07:42
Anti-TNF nella malattia di Crohn, in quali situazioni fisio-patologiche interrompere il trattamento?
0:21:13
Update on vedolizumab in IBD: What have we learned?
0:05:50
Vedolizumab Safe for Inflammatory Bowel Disease – IBD in the News
0:20:09
ANTI TNF O VEDOLIZUMAB EN COLITIS ULCERATIVA
0:01:03
Dr Guerra: Estudio Eneida sobre Psoriasis asociada a tto con anti-TNF
0:01:19
¿Qué objetivo se marca cuando utiliza Adacolumn® en combinación con Anti-TNF?
0:02:08
¿Qué objetivo se marca cuando utiliza Adacolumn® en combinación con Anti-TNF?
Комментарии